Publication: Regulatory B cells, A to Z
dc.contributor.author | Jansen, Kirstin | |
dc.contributor.author | Cevhertaş, Laçin | |
dc.contributor.author | Ma, Siyuan | |
dc.contributor.author | Satitsuksanoa, Pattraporn | |
dc.contributor.author | Akdis, Mubeccel | |
dc.contributor.author | van de Veen, Willem | |
dc.contributor.buuauthor | Cevhertaş, Laçin | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Sağlık Bilimleri Enstitüsü/Tıbbi İmmünoloji Bölümü. | |
dc.contributor.researcherid | FYD-1431-2022 | |
dc.date.accessioned | 2024-06-13T13:23:01Z | |
dc.date.available | 2024-06-13T13:23:01Z | |
dc.date.issued | 2021-02-02 | |
dc.description.abstract | B cells play a central role in the immune system through the production of antibodies. During the past two decades, it has become increasingly clear that B cells also have the capacity to regulate immune responses through mechanisms that extend beyond antibody production. Several types of human and murine regulatory B cells have been reported that suppress inflammatory responses in autoimmune disease, allergy, infection, transplantation, and cancer. Key suppressive molecules associated with regulatory B-cell function include the cytokines IL-10, IL-35, and TGF-beta as well as cell membrane-bound molecules such as programmed death-ligand 1, CD39, CD73, and aryl hydrocarbon receptor. Regulatory B cells can be induced by a range of different stimuli, including microbial products such as TLR4 or TLR9 ligands, inflammatory cytokines such as IL-6, IL-1 beta, and IFN-alpha, as well as CD40 ligation. This review provides an overview of our current knowledge on regulatory B cells. We discuss different types of regulatory B cells, the mechanisms through which they exert their regulatory functions, factors that lead to induction of regulatory B cells and their role in the alteration of inflammatory responses in different diseases. | |
dc.description.sponsorship | Swiss National Science Foundation (SNSF) - 320030-159870 - 310030_179428 | |
dc.description.sponsorship | Sean N Parker Center for Allergy and Asthma Research at Stanford University | |
dc.description.sponsorship | Christine Kuhne-Center for Allergy Research and Education (CK-CARE) | |
dc.description.sponsorship | Swiss National Science Foundation (SNSF) - 320030_159870 - 310030_179428 | |
dc.identifier.doi | 10.1111/all.14763 | |
dc.identifier.eissn | 1398-9995 | |
dc.identifier.endpage | 2715 | |
dc.identifier.issn | 0105-4538 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 2699 | |
dc.identifier.uri | https://doi.org/10.1111/all.14763 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/all.14763 | |
dc.identifier.uri | https://hdl.handle.net/11452/42173 | |
dc.identifier.volume | 76 | |
dc.identifier.wos | 000629281200001 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.journal | Allergy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Experimental autoimmune encephalomyelitis | |
dc.subject | Aryl-hydrocarbon receptor | |
dc.subject | B10 cells | |
dc.subject | T-cells | |
dc.subject | Rheumatoid-arthritis | |
dc.subject | Tnf-alpha | |
dc.subject | In-vitro | |
dc.subject | Il-10 | |
dc.subject | Induction | |
dc.subject | Inflammation | |
dc.subject | Allergy | |
dc.subject | Autoimmunity | |
dc.subject | Breg cells | |
dc.subject | 10 | |
dc.subject | Inflammation | |
dc.subject | Suppression | |
dc.subject | Tolerance | |
dc.subject | Allergy | |
dc.subject | Immunology | |
dc.title | Regulatory B cells, A to Z | |
dc.type | Review | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1